S-1-Propenyl-ʟ-cysteine (S1PC) is a stereoisomer of S-1-Propenyl-ʟ-cysteine (SAC), an important sulfur-containing amino acid that plays a role for the beneficial pharmacological effects of aged garlic extract (AGE). The existence of S1PC in garlic preparations has been known since the 1960’s. However, there was no report regarding the biological and/or pharmacological activity of S1PC until 2016. Recently, we performed a series of studies to examine the chemical, biological, pharmacological and pharmacokinetic properties of S1PC, and obtained some interesting results. S1PC existed only in trace amounts in raw garlic, but its concentration increased almost up to the level similar of SAC through aging process of AGE. S1PC showed immunomodulatory effects in vitro and in vivo, and reduced blood pressure in a hypertensive animal model. A pharmacokinetic study revealed that S1PC was readily absorbed after oral administration in rats and dogs with bioavailability of 88–100%. Additionally, S1PC had little inhibitory influence on human cytochrome P450 activities, even at a concentration of 1 mM. Based on these findings, S1PC was suggested to be another important, pharmacologically active and safe component of AGE similar to SAC. In this review, we highlight some results from recent studies on S1PC and discuss the potential medicinal value of S1PC.
27 December 2019 in Experimental and Therapeutic Medicine
Raw garlic contains characteristic compounds, such as S‑alk(en)ylcysteine sulfoxides, γ‑glutamyl‑S‑alk(en)-ylcysteines and polysaccharides. These compounds undergo various transformation processes during the aging process. Among these compounds, the change of sulfur‑containing molecules is diverse and time‑dependent. Previously, by means of the liquid chromatography (LC)/LC‑mass spectrometry (MS) method, a number of unidentified peaks corresponding to candidates of sulfur‑containing molecules were detected in the chromatogram of aged garlic extract (AGE), and identified using MS and nuclear magnetic resonance (NMR). The production mechanisms of these compounds were then examined by model reactions and laboratory experiments mimicking the aging process. Three γ‑glutamyl tripeptides [γ‑glutamyl‑γ‑glutamyl‑S‑methylcysteine, γ‑glutamyl‑γ‑gluta-myl‑S‑allylcysteine (GGSAC), γ‑glutamyl‑γ‑glutamyl‑S‑1‑propenylcysteine], γ‑glutamyl‑S‑allylmercaptocysteine (GSAMC) and cis‑S‑1‑propenylcysteine (cis‑S1PC) were isolated and identified. GGSAC was produced from GSAC through the enzymatic reaction catalyzed by γ‑glutamyltranspeptidase (GGT), and two other tripeptides could be produced in similar reactions. GSAMC was produced by the reaction between γ‑glutamyl dipeptides and allicin. Furthermore, GSAMC was a precursor compound of S‑allyl-mercaptocysteine (SAMC), and thus it was produced from GSAMC by GGT. cis‑S1PC was produced from trans‑S1PC by the isomerization reaction. A number of other compounds were also identified, including Maillard reaction products; however, their production mechanisms have not been elucidated. In this review, we present the changes in characteristic constituents in raw garlic and garlic extract during the aging process and discuss their production mechanisms involving the various chemical and enzymatic reactions.
Elevated blood pressure is a major risk factor for cardiovascular diseases. Although some effective drug treatments are available, a relatively large proportion of patients have uncontrolled blood pressure. Dietary supplements are used for the prevention and treatment of hypertension as complementary and alternative medicines. Of the various dietary supplements, antioxidants, fish oil and diverse herbal products are commonly used. Within this context, it is important to determine the actual effectiveness and possible side‑effects of these supplements; however, some of the products have been poorly investigated for their effects and safety. In the current review, we focus on garlic and several other dietary supplements, such as coenzyme Q10, fish oil and probiotics, that have exhibited significant beneficial effects on blood pressure in clinical trials. In addition, we discuss the possible mechanisms of action responsible for their anti‑hypertensive effects, as well as the safety, active ingredients and their potential use as adjunct therapies for uncontrolled hypertension.
1 September 2015 in Biochemical and Biophysical Research Communications
Garlic (Allium sativum L.) and its aged extract contain many bioactive compounds that can bring health benefits to humans. Among them, S-1-propenyl-L-cysteine (S1PC) has recently drawn significant attention in the field of nutriceutical research. However, the mechanism of its molecular action has remained poorly understood. Here, we show that S1PC significantly activates liver kinase B1 (LKB1) through enhancing its tertiary complex formation with STRAD and MO25, leading to stimulating the phosphorylation of a mammalian NAD+-dependent protein deacetylase, SIRT1, and promoting the secretion of extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in white adipose tissue (WAT). Interestingly, eNAMPT secreted from WAT specifically targets the hypothalamus, significantly enhancing skeletal muscle force and improving frailty indices in aged mice. Furthermore, S1PC is also able to increase circulating eNAMPT levels in human individuals who maintain healthy adipose mass. These findings demonstrate that S1PC specifically stimulates the LKB1-SIRT1 pathway and enhances eNAMPT secretion in WAT, counteracting skeletal muscle aging in aged individuals.